Last reviewed · How we verify

NCT03989921: IRO

Ovarian Reserve and Embryo Implantation

Completed Last updated 18 June 2019
What this trial tests

trial testing no intervention. observational study in Ovarian Reserve in 598 participants. Completed in 30 April 2019.

Timeline
29 November 2018
Primary endpoint
30 April 2019
30 April 2019

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Nīmes
StatusCompleted
Study typeOBSERVATIONAL
Enrollment598
Start date29 November 2018
Primary completion30 April 2019
Estimated completion30 April 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Nīmes

Who can join

35 and older, female only, with Ovarian Reserve or IVF. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare, in young patients with In vitro fertilization (IVF), the rate of embryo implantation by early culture transfer (J2-J3) between 2 groups of patients: "normo responders" vs. "poor responders".

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ovarian Reserve

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Nīmes trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03989921.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing